JUNS

Jupiter Neurosciences (JUNS)

About Jupiter Neurosciences (JUNS)

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.

Details

Daily high

$1.22

Daily low

$1.13

Price at open

$1.21

52 Week High

$19.51

52 Week Low

$0.51

Market cap

39.2M

Dividend yield

0.00%

Volume

37,099

Avg. volume

43,985

P/E ratio

-5.01

Jupiter Neurosciences News